Literature DB >> 19900405

Proteolytic cleavage of the rat heparan sulfate 6-O-endosulfatase SulfFP2 by furin-type proprotein convertases.

Satoshi Nagamine1, Kazuko Keino-Masu, Kensuke Shiomi, Masayuki Masu.   

Abstract

Heparan sulfate 6-O-endosufatases Sulf1 and Sulf2 hydrolyze the 6-O-sulfate of the glucosamine residues in heparin and heparan sulfate, thereby regulating multiple signaling pathways. A previous study reported that human Sulf1 and Sulf2 were proteolytically processed in a manner sensitive to a furin inhibitor. However, the exact sites of cleavage, the sequence motifs for proteolysis, and the effect of the cleavage on enzyme activity remain unknown. Here we show that the cleavage of rat Sulf2 (also called SulfFP2) occurs at two arginine residues, 543 and 570, in the hydrophilic domain. Both sites reside in the consensus sequence for the cleavage by furin-type proprotein convertases, and the consensus motifs are essential for cleavages. The cleavage at arginine 570 is sensitive to a furin inhibitor. Furthermore, the uncleavable form of SulfFP2 shows sulfatase activity comparable to the cleavable SulfFP2, indicating that the cleavage is not indispensable for activation of SulfFP2. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19900405     DOI: 10.1016/j.bbrc.2009.11.011

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate.

Authors:  Steven D Rosen; Hassan Lemjabbar-Alaoui
Journal:  Expert Opin Ther Targets       Date:  2010-09       Impact factor: 6.902

2.  Organ-specific sulfation patterns of heparan sulfate generated by extracellular sulfatases Sulf1 and Sulf2 in mice.

Authors:  Satoshi Nagamine; Michiko Tamba; Hisako Ishimine; Kota Araki; Kensuke Shiomi; Takuya Okada; Tatsuyuki Ohto; Satoshi Kunita; Satoru Takahashi; Ronnie G P Wismans; Toin H van Kuppevelt; Masayuki Masu; Kazuko Keino-Masu
Journal:  J Biol Chem       Date:  2012-02-01       Impact factor: 5.157

3.  Role of heparan sulfatases in ovarian and breast cancer.

Authors:  Ashwani Khurana; Daniah Beleford; Xiaoping He; Jeremy Chien; Viji Shridhar
Journal:  Am J Cancer Res       Date:  2013-01-18       Impact factor: 6.166

Review 4.  Heparan sulfate S-domains and extracellular sulfatases (Sulfs): their possible roles in protein aggregation diseases.

Authors:  Kazuchika Nishitsuji
Journal:  Glycoconj J       Date:  2018-07-12       Impact factor: 2.916

Review 5.  Post-Synthetic Regulation of HS Structure: The Yin and Yang of the Sulfs in Cancer.

Authors:  Romain R Vivès; Amal Seffouh; Hugues Lortat-Jacob
Journal:  Front Oncol       Date:  2014-01-14       Impact factor: 6.244

Review 6.  The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics.

Authors:  Edward Hammond; Ashwani Khurana; Viji Shridhar; Keith Dredge
Journal:  Front Oncol       Date:  2014-07-24       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.